Boston Scientific Corp (BSX)vsKoninklijke Philips NV ADR (PHG)
BSX
Boston Scientific Corp
$69.48
-0.59%
HEALTHCARE · Cap: $103.56B
PHG
Koninklijke Philips NV ADR
$26.25
-2.27%
HEALTHCARE · Cap: $27.08B
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 13% more annual revenue ($20.07B vs $17.83B). BSX leads profitability with a 14.4% profit margin vs 5.0%. PHG appears more attractively valued with a PEG of 0.36. BSX earns a higher WallStSmart Score of 63/100 (C+).
BSX
Buy63
out of 100
Grade: C+
PHG
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+1.0%
Fair Value
$70.62
Current Price
$69.48
$1.14 discount
Margin of Safety
-340.5%
Fair Value
$7.28
Current Price
$26.25
$18.97 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
15.9% revenue growth
Generating 1.0B in free cash flow
Growing faster than its price suggests
Revenue surging 110.0% year-over-year
Reasonable price relative to book value
Generating 1.3B in free cash flow
Areas to Watch
Premium valuation, high expectations priced in
Moderate valuation
ROE of 7.8% — below average capital efficiency
5.0% margin — thin
Earnings declined 50.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bull Case : PHG
The strongest argument for PHG centers on PEG Ratio, Revenue Growth, Price/Book. Revenue growth of 110.0% demonstrates continued momentum. PEG of 0.36 suggests the stock is reasonably priced for its growth.
Bear Case : BSX
The primary concerns for BSX are P/E Ratio.
Bear Case : PHG
The primary concerns for PHG are P/E Ratio, Return on Equity, Profit Margin.
Key Dynamics to Monitor
BSX profiles as a growth stock while PHG is a hypergrowth play — different risk/reward profiles.
PHG carries more volatility with a beta of 0.94 — expect wider price swings.
PHG is growing revenue faster at 110.0% — sustainability is the question.
PHG generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (63/100 vs 49/100) and 15.9% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Koninklijke Philips NV ADR
HEALTHCARE · MEDICAL DEVICES · USA
Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally. The company is headquartered in Amsterdam, the Netherlands.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?